Inmed pharmaceuticals reports third quarter fiscal 2022 financial results and provides business update

Vancouver, british columbia and south san francisco, calif., may 13, 2022 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq: inm), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced financial results for the third quarter of the fiscal year 2022 which ended march 31, 2022.
INM Ratings Summary
INM Quant Ranking